Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Research & Development (2017 - 2025)

Inspire Medical Systems' Research & Development history spans 9 years, with the latest figure at $24.9 million for Q4 2025.

  • For Q4 2025, Research & Development fell 17.78% year-over-year to $24.9 million; the TTM value through Dec 2025 reached $103.2 million, down 9.61%, while the annual FY2025 figure was $103.2 million, 9.61% down from the prior year.
  • Research & Development for Q4 2025 was $24.9 million at Inspire Medical Systems, up from $24.2 million in the prior quarter.
  • Across five years, Research & Development topped out at $31.1 million in Q4 2023 and bottomed at $8.2 million in Q1 2021.
  • The 5-year median for Research & Development is $25.2 million (2023), against an average of $22.0 million.
  • The largest annual shift saw Research & Development surged 118.36% in 2022 before it decreased 17.78% in 2025.
  • A 5-year view of Research & Development shows it stood at $10.3 million in 2021, then skyrocketed by 106.41% to $21.2 million in 2022, then surged by 46.14% to $31.1 million in 2023, then fell by 2.31% to $30.3 million in 2024, then dropped by 17.78% to $24.9 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Research & Development are $24.9 million (Q4 2025), $24.2 million (Q3 2025), and $26.2 million (Q2 2025).